The aim of the study was to evaluate the prevalence of carotid artery disease in type 2 diabetes patients with coronary artery disease, and to establish the influence of metabolic factors on its occurrence.
In all, 145 patients (aged 59.85±8.43 years, diabetes duration 8.89±6.29 years) were randomly selected in a cross-sectional study. Carotid ultrasound was used for evaluation of the presence of carotid plaque (CP) and stenosis (CS). A logistic regression model was constructed to define the influence of risk factors - arterial hypertension, systolic blood pressure, weight, waist to hip ratio, high blood glucose and plasma lipid levels.
Carotid artery disease was present in these patients with a prevalence of 81.9% for CP, 25.2% for unilateral CS and 13.5% for bilateral CS. The low-density lipoprotein (LDL) cholesterol level was an independent predictor for CS (OR 1.936; 95% CI 1.241-3.026). Non-high density lipoprotein (HDL) cholesterol (OR 1.374; 95% CI 1.035-1.825) and glycaemia (OR 1.214; 95% CI 1.022-1.442) were predictors for carotid plaque.
1. Kissela BM, Khoury J, Kleindorfer D. et al. Epidemiology of ischemic stroke in patients with diabetes. The Greater Cincinnati/Northern Kentucky Stroke study. Diabetes Care2005;28:355–9.
2.
2. van Wijk I, Kappelle LJ, van Gijn J et al. Long-term survival and vascular event risk after transient ischemic attack or minor ischemic stroke: a cohort study. Lancet2005;365:2098–104.
3.
3. Idris I, Thomson GA, Sharma JC.Diabetes mellitus and stroke. Int J Clin Pract2006;60(1):48–56.
4.
4. Kiechl S, Willeit J, for Bruneck Study Group.The natural course of atherosclerosis, part 1: incidence and progression. Arterioscler Thromb Vasc Biol1999;34:1484–90.
5.
5. Yang B, Li TD, Wang JS, Zhi G, Jin WS, Xu Y.Insulin resistance and carotid atherosclerosis in 221 patients with potential hyperglycemia. Chin Med Sci2005;20:108–11.
7. Bonora E, Tessari R, Micciolo R. et al. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. Diabetes Care1997;20:627–31.
8.
8. Wagenknecht LE, D'Agostino R Jr, Savage PJ, O'Leary DH, Saad MF, Haffner SM.Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke1997;28:999–1005.
9.
9. Folsom AR, Rasmunssen ML, Chambles ME. et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ishaemic stroke. ARIC study. Diabetes Care1999;22:1077–83.
10.
10. Megherbi SA, Mialn C, Minier D. et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke. Data from the European BIOMED Stroke project. Stroke2003;344:688–94.
11.
11. Stevens RJ, Coleman RL, Adler A. et al. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes. UKPDS 66. Diabetes Care2004;27:201–07.
12.
12. Williams R, Aiery M.Epidemiology and pathogenesis of diabetic angiopathy. In: Tooke J. Diabetic angiopathy. Arnold, London. 1999:7–19.
13.
13. Ford ES, Giles WH, Dietz WH.Prevalence of the metabolic syndrome among US adults. JAMA2002;287:356–9.
14.
14. Pollex R, Al-Shalli KZ, House AA. et al. Relationship of metabolic syndrome to carotid ultrasound traits. Cardiovascular Ultrasound2006;4:28–35.
15.
15. De Angelis M, Scrucca L, Leandri M. et al. Prevalence of carotid stenosis in type 2 diabetic patients asymptomatic for cerebrovascular disease. Diabetes Nutr Metab2003;16(1):48–55.
16.
16. Lacroix P, Aboyyans V, Criqui MH. et al. Type-2 diabetes and carotid stenosis: a proposal for a screening strategy in asymptomatic patients. Vasc Med2006;11(2):93–9.
17.
17. Lu W, Resnick HE, Jablonski KA. et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care2003;26:16–23.
18.
18. Jiang R, Schulze M, Li T. et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care2004;27:1991–7.
19.
19. De Vries R, Perton GF, Dallinga-Thie GM et al. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes2005;54:3554–9.
20.
20. Packard CJ, Saito Y.Non-HDL cholesterol as a measure of atherosclerotic risk. J Atherosclerosis Thromb2003;11:6–14.
21.
21. Liu L, Sempos C, Donahue R. et al. Joint distribution on non-HDL and LDL cholesterol and coronary heart disease risk reduction among individuals with and without diabetes. Diabetes Care2005;28:1916–21.
22.
22. Grundy SM, Cleeman JI, Merz CN. et al. National Heart, Lung, and Blood Institute; ACC; AHA. Implications of recent clinical trials for the National Cholesterol Education Program ATP III guidelines. Circulation2004;110:227–39.
23.
23. Kawamoto R, Tomita H, Oka Y. et al. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Int Med2005;44:1232–8.
24.
24. Hulthe J, Bokemartk L, Wikstrand J. et al. The metabolic syndrome, LDL particle size, and atherosclerosis: The AIR study. Arterioscler Thromb Vasc Biol2000;20:2140–7.
25.
25. Turner R, Millns H, Neil HA. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: UKPDS 23. BMJ1998;316:823–8.
26.
26. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR.UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care2002;25:894–9.
27.
27. Bonora E, Kiechl E, Oberhollenzer F. et al. Impaired glucose tolerance, type 2 diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia2000;43:156–64.
28.
28. Selvin E, Coresh J, Golden SH. et al. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in type 2 diabetes. The Atherosclerosis Risk in Communities Study. Diabetes Care2005;28:1963–75.
29.
29. Tropeano AI, Boutouyrie P, Katsahian S. et al. Glucose level is a major determinant of carotid intima-media thickness in patients with hypertension and hyperglycemia. J Hypertens2004;22:2153–60.
30.
30. Rajala U, Laakso M, Paivansalo M.Low insulin sensitivity measured by both quantitative insulin sensitive check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery. J Clin Endocrinol Metab2002;87:5092–7.
31.
31. Czernichow S, Bertrais S, Oppert JM. et al. Body composition and fat repartition in relation to structure and function of large arteries in middle-aged adults (the SU.VI.MAX study). Int J Obes2005;29:826–32.
